166 related articles for article (PubMed ID: 22716255)
1. SERPINE1 expression discriminates site-specific metastasis in human melanoma.
Klein RM; Bernstein D; Higgins SP; Higgins CE; Higgins PJ
Exp Dermatol; 2012 Jul; 21(7):551-4. PubMed ID: 22716255
[TBL] [Abstract][Full Text] [Related]
2. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.
Wu KN; Queenan M; Brody JR; Potoczek M; Sotgia F; Lisanti MP; Witkiewicz AK
Cell Cycle; 2011 Dec; 10(24):4250-5. PubMed ID: 22134245
[TBL] [Abstract][Full Text] [Related]
3. Tissue- and urokinase-type plasminogen activators and type 1 plasminogen activator inhibitor in melanomas and benign skin pigment neoplasms.
Gershtein ES; Medvedeva SV; Babkina IV; Kushlinskii NE; Trapeznikov NN
Bull Exp Biol Med; 2001 Jul; 132(1):670-4. PubMed ID: 11687850
[TBL] [Abstract][Full Text] [Related]
4. Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
Arroyo-Solera I; Pavón MÁ; León X; López M; Gallardo A; Céspedes MV; Casanova I; Pallarès V; López-Pousa A; Mangues MA; Barnadas A; Quer M; Mangues R
Head Neck; 2019 Feb; 41(2):429-439. PubMed ID: 30548470
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P
J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin.
Singh RK; Varney ML; Bucana CD; Johansson SL
Melanoma Res; 1999 Aug; 9(4):383-7. PubMed ID: 10504057
[TBL] [Abstract][Full Text] [Related]
7. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels.
Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J
Oncology; 2003; 64(4):374-9. PubMed ID: 12759535
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein in melanoma progression.
Kanoko M; Ueda M; Nagano T; Ichihashi M
J Dermatol Sci; 1996 Jun; 12(2):97-103. PubMed ID: 8814540
[TBL] [Abstract][Full Text] [Related]
9. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.
Thies A; Schachner M; Berger J; Moll I; Schulze HJ; Brunner G; Schumacher U
J Pathol; 2004 Aug; 203(4):933-9. PubMed ID: 15258996
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic vessel density and VEGF-C expression as independent predictors of melanoma metastases.
Špirić Z; Eri Ž; Erić M
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1653-1659. PubMed ID: 28756123
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.
Hugdahl E; Bachmann IM; Schuster C; Ladstein RG; Akslen LA
PLoS One; 2019; 14(1):e0210399. PubMed ID: 30640942
[TBL] [Abstract][Full Text] [Related]
13. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.
Mazzoccoli G; Pazienza V; Panza A; Valvano MR; Benegiamo G; Vinciguerra M; Andriulli A; Piepoli A
J Cancer Res Clin Oncol; 2012 Mar; 138(3):501-11. PubMed ID: 22198637
[TBL] [Abstract][Full Text] [Related]
14. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory metastatic melanoma.
Flórez A; Sánchez-Aguilar D; Peteiro C; Peñaranda JM; Toribio J
J Cutan Pathol; 1999 Feb; 26(2):105-8. PubMed ID: 10082402
[TBL] [Abstract][Full Text] [Related]
16. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
17. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions.
Frey K; Fiechter M; Schwager K; Belloni B; Barysch MJ; Neri D; Dummer R
Exp Dermatol; 2011 Aug; 20(8):685-8. PubMed ID: 21649738
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
